New Roles of Glycosaminoglycans in α-Synuclein Aggregation in a Cellular Model of Parkinson Disease
Sonia Lehri-Boufala(Centre National de la Recherche Scientifique), Christophe Morin(Centre National de la Recherche Scientifique), Mohand Ouidir Ouidja(Centre National de la Recherche Scientifique), Laure Garrigue‐Antar(Centre National de la Recherche Scientifique), Emilie Hénault(Centre National de la Recherche Scientifique), Véronique Barbier-Chassefière(Centre National de la Recherche Scientifique), Dulce Papy-García(Université Paris-Est Créteil), Rita Raisman‐Vozari(Centre National de la Recherche Scientifique)
Cited by 50
Related Papers
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
|Proceedings of the National Academy of Sciences|2013|864
Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions
|Journal of Biological Chemistry|2005|175
Novel tactics for neuroprotection in Parkinson's disease: Role of antibiotics, polyphenols and neuropeptides
|Progress in Neurobiology|2015|163
The 37‐kDa/67‐kDa Laminin Receptor Acts as a Receptor for Infectious Prions and Is Inhibited by Polysulfated Glycanes
|The Journal of Infectious Diseases|2006|126